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Abstract 
 
EFFECTS OF PERIPHERAL REVASCULARIZATION ON BLOOD PRESSURE AND 
CALF MUSCLE OXYGEN SATURATION IN PERIPHERAL ARTERY DISEASE 
 
 
J. Carter Luck  
B.S., Lees-McRae College 
M.S., Appalachian State University 
 
 
Chairperson:  Abigail L. Stickford, Ph.D.  
 
 
  Peripheral artery disease (PAD) reduces oxygen supply to exercising skeletal 
muscle in the lower extremity due to atherosclerotic reductions in blood flow. During 
exercise, a feedback mechanism sensitive to metabolic and mechanical stimuli, 
known as the exercise pressor reflex, serves to redistribute blood flow to active 
skeletal muscle. However, in individuals with PAD, there is an exaggerated exercise 
pressor reflex in response to lower extremity exercise thought to be caused, in part, by 
compromised blood flow. Endovascular and surgical revascularization procedures 
have been important for treating impaired limb perfusion caused by moderate to 
severe PAD. However, to what extent these procedures improve tissue perfusion 
during exercise or normalize the exercise pressor reflex remains unknown. Purpose: 
To examine whether revascularization reduces the exercise pressor reflex and 
improves skeletal muscle oxygen saturation (SmO2) measured using near-infrared 
spectroscopy (NIRS) in the leg during foot exercise in patients with PAD. Methods: 
 v 
Patients with symptomatic PAD (n = 6) performed incremental supine plantar flexion 
exercise, starting at 0.5 kg and increased by 0.5 kg every minute for up to 14 minutes, 
pre- and one-month post peripheral revascularization procedure. Exercise was 
terminated when patients self-reported moderate calf muscle pain (i.e., claudication). 
SmO2 was measured continuously from the anteromedial aspect of the gastrocnemius 
muscle belly, while heart rate and blood pressure were measured beat-by-beat. 
Results: Reductions in SmO2 from baseline to the 1.5 kg stage were attenuated post-
revascularization when compared to pre-intervention (-6.5 ± 6.2% vs. -39.8 ± 22.5%, 
P < .05). The change in mean arterial blood pressure was reduced post-
revascularization (4 ± 4 mmHg vs. 16 ± 12 mmHg P < .05). PAD patients exercised 
longer post-revascularization (5.8 ± 0.4 min vs. 4.0 ± 1.5 min P < .05).  Conclusions: 
These data suggest that revascularization reverses the rapid decline in SmO2 during 
exercise, reduced the heart rate response, and may partially attenuate the blood 
pressure response in patients with PAD. 
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Chapter 1 
Introduction 
 
Peripheral artery disease (PAD) is classically defined as atherosclerosis of large conduit 
arteries that supply the lower extremity (Hirsch et al., 2001). It is a chronic, progressive, and 
debilitating disease reported to affect nearly 8 – 12 million Americans (Allison et al., 2007; 
Falk, 2006; Hiatt et al., 2008; Hirsch et al., 2001; Selvin & Erlinger, 2004). Leg blood flow is 
reduced in PAD as a consequence of diseased arteries that become narrowed by plaque 
formation in the arterial wall. The reduction in blood flow is particularly problematic during 
periods when the metabolic demands of active skeletal muscle outweigh the ability of the 
vasculature to supply blood. As a result, PAD patients may experience localized cramping leg 
pain with physical exertion. Leg pain that is induced by physical activity and is alleviated with 
rest is termed “intermittent claudication.” In many PAD patients, claudication may occur 
during light ambulation (i.e., walking or climbing stairs) and is associated with significant 
reductions in functional ability and quality of life (Hernandez et al., 2019).  
Treatment options for individuals diagnosed with PAD are surprisingly few compared 
to other forms of cardiovascular disease. Aggressive risk factor modification (especially 
smoking cessation) and management of comorbidities, including hypertension, diabetes, and 
dyslipidemia, are appropriate for the initial management of PAD. There are few 
pharmacological treatments. Only two medications, cilostazol and pentoxifylline, are approved 
for treating claudication with cilostazol being the more effective of the two (Dawson et al., 
2000). Other treatments include drugs that reduce the risk of cardiovascular events such as 
anti-platelets and statins. Recently, national coverage for supervised exercise therapy in 
patients with PAD has been approved for Medicare beneficiaries and has proven to be one of 
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the more promising treatment options in PAD management (Treat-Jacobson et al., 2019). 
Surgical bypass and catheter-based endovascular revascularization procedures (Figure 1) are 
typically reserved for patients with moderate-to-severe symptoms and functional impairments.  
 
Figure 1. Endovascular and surgical revascularization for the treatment of peripheral artery 
disease. 
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Recently, peripheral revascularization procedures, that are the standard of care for the 
restoration of blood flow to the leg, are increasing in frequency for the treatment of 
symptomatic PAD (Creswell & Abelson, 2015). Between the years 1980 and 2000, Anderson 
and colleagues reported a 500-fold increase in all catheter-based interventions for treating 
peripheral atherosclerosis (P. L. Anderson et al., 2004). While the oxygen supply-demand 
mismatch is addressed with peripheral revascularization, the procedure does not fully 
normalize exercise capacity or abolish symptoms in all patients (Regensteiner, Hargarten, 
Rutherford, & Hiatt, 1993). However, in some individuals, revascularization could improve 
the cardiovascular response to exercise. It is a well-established observation that patients with 
PAD have an exaggerated blood pressure response to exercise when compared to healthy 
individuals (Baccelli et al., 1999; Bakke, Hisdal, Jorgensen, Kroese, & Stranden, 2007; Luck 
et al., 2017; Miller et al., 2018; Miller et al., 2017; Muller et al., 2012; Muller et al., 2015; 
Reggiani et al., 1999), and this relativity is associated with a greater cardiovascular disease 
risk (de et al., 2008). The augmented blood pressure response is likely attributed to an 
engagement of the exercise pressor reflex. The exercise pressor reflex is a sensory feedback 
mechanism, originating in the contracting skeletal muscle, that serves to modulate 
cardiorespiratory adjustments to meet the metabolic demands of exercise (Michelini & Stern, 
2009; Mitchell, 2012). The EPR is comprised of two sensory components, specifically the 
muscle mechanoreflex and muscle metaboreflex (Boushel, 2010; McCloskey & Mitchell, 
1972; Mitchell, Kaufman, & Iwamoto, 1983). Mechanically and chemically sensitive receptors 
in contracting skeletal muscle stimulate thinly myelinated group III afferents and unmyelinated 
group IV afferents that evoke the EPR (Kaufman, Longhurst, Rybicki, Wallach, & Mitchell, 
1983; Kaufman, Rybicki, Waldrop, & Ordway, 1984). This exercise-induced increase in 
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sensory nerve activity stimulates cardiovascular control areas in the brainstem that increase 
sympathetic nerve activity and decrease parasympathetic nerve activity. This reflex is a 
necessary component for redirecting blood flow to active skeletal muscle. Although it has not 
been explicitly shown in PAD, it is unlikely that the exaggerated exercise pressor reflex is 
sufficient to overcome the occlusive disease during moderate to vigorous exercise (Miller et 
al., 2017).  
As PAD is a blood flow limiting disease, it is not surprising that during exercise patients 
have a greater reduction in calf muscle oxygen saturation (SmO2) compared to healthy 
individuals (Gardner et al., 2019; Luck et al., 2017; McCully, Halber, & Posner, 1994; Miller 
et al., 2017). SmO2 is assessed by non-invasive near-infrared spectroscopy (NIRS). NIRS is a 
technique that utilizes the light absorbing properties of oxygenated hemoglobin (O2Hb), 
deoxygenated hemoglobin (HHb), and myoglobin, to assess local oxygenation in a superficial 
skeletal muscle. Light that is emitted from the NIRS monitor penetrates skeletal muscle and is 
absorbed by varying concentrations of HbO2 and HHb. Changes in these concentrations can 
be detected during exercise and quantified based on the known absorptive properties of 
hemoglobin (Figure 2). Exercise-induced reductions in SmO2, that are indicative of supply-
demand imbalances in the microvasculature of active skeletal muscle, appear to accompany 
the exaggerated exercise pressor reflex in PAD (Luck et al., 2017; Miller et al., 2017). A 
previous study in our laboratory showed that revascularization improves the blood pressure 
responses to dynamic foot exercise (Miller et al., 2018). It is suspected that increased perfusion 
to the exercising skeletal muscle attenuates the exercise pressor reflex in PAD. However, this 
has not been explicitly tested. The present study is designed to evaluate whether peripheral 
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revascularization (endovascular or surgical) reverses the rapid decline in active muscle SmO2 
during plantar flexion exercise, as well as reduce the accentuated EPR in PAD.  
 
Figure 2. A basic schematic representation of a near-infrared spectroscopy (NIRS) monitor. 
Light is injected into a superficial skeletal muscle from a light emitting diode and is detected 
by a photodetector. The penetration depth is roughly one-half the distance between the light 
emitter and the detector. Oxygenated hemoglobin (O2Hb) and deoxygenated hemoglobin 
(HHb) have different light absorptive properties allowing for the measurement of muscle 
oxygen saturation (SmO2). SmO2 is the ratio of O2Hb and total hemoglobin (tHb) expressed as 
a percentage.  
 
Statement of the Problem 
 
The problem of the study is that it remains to be fully elucidated as to what degree the 
restoration of blood flow (via peripheral revascularization) improves active skeletal muscle 
oxygenation or reduces the augmented exercise pressor reflex in PAD.  
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Purpose of the Study 
 
The purpose of the study is to examine whether 1.) leg revascularization increases calf 
muscle SmO2 during foot exercise and 2.) whether the peripheral revascularization reduces the 
exaggerated exercise pressor reflex in patients with symptomatic PAD.  
 
Justification for the Study 
 
Peripheral revascularization procedures are performed to treat symptomatic PAD with 
the objective of improving perfusion to the tissues of the lower extremity. A procedure is 
considered “successful” with an improvement in the systolic ankle-to-brachial index (ABI 
>0.15) (M. M. McDermott et al., 2013). An ABI ≤ 0.90 is indicative of occlusive disease in 
the arteries supplying the lower extremity, where a lower ABI value is predictive of greater 
severity (Gardner & Afaq, 2008).  However, these procedures do not reverse atherosclerotic 
disease as they do not alter the underlying pathogenic mechanisms. Restenosis or recurrent 
occlusions are the leading complication following peripheral revascularization (de Donato et 
al., 2017; Setacci et al., 2012) and symptoms may persist in many patients (T. W. Rooke et al., 
2011). While emerging research indicates that the pathophysiology of PAD is far more 
complex than simply reductions in blood flow (Stewart, Hiatt, Regensteiner, & Hirsch, 2002), 
it is the general consensus that the chronic occlusive disease initiates abnormalities in the 
skeletal muscle. Recent work has shown that restoring blood flow via revascularization may 
slow the progression of fibrosis and scarring in the skeletal muscle (Ha et al., 2016). However, 
it is not fully understood why some patients continue to experience symptoms following these 
endovascular and surgical interventions that improve or sometimes normalize the ABI. It is 
also important to note that while walking ability tends to improve following revascularization 
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(Fakhry, Spronk, van der Laan, & et al., 2015), functionality certainly is not restored to normal 
levels in most patients.           
Mismatches in O2 supply and demand compromise oxidative metabolism in active 
skeletal muscle and can be easily and noninvasively monitored using near-infrared 
spectroscopy (NIRS). NIRS has been previously used to measure oxygenation responses 
within exercising leg muscles in PAD patients (Bauer, Brass, Barstow, & Hiatt, 2007; Beckitt, 
Day, Morgan, & Lamont, 2012; Luck et al., 2017; McCully et al., 1994; McCully, Landsberg, 
Suarez, Hofmann, & Posner, 1997). Previous studies have shown that reductions in active 
muscle SmO2 are greater in patients with PAD (Bauer et al., 2007; Bauer, Brass, & Hiatt, 2004; 
Luck et al., 2017; Miller et al., 2017). Recent work in our lab has shown that the blood pressure 
response to exercise is attenuated one-month post revascularization (Miller et al., 2018). 
However, to what extent the altered blood pressure response is associated with improvements 
in SmO2 remains unclear.   
Assumptions and Limitations  
 
Interpretations of the results from the present study considered the following 
assumptions and limitations: 
1. There was no control group.  
2. The physiological calibration for the NIRS device could not be performed 
because it could potentially compromise the integrity of the implanted stent in 
the leg; thus, comparing the absolute values to other NIRS devices is not 
recommended.  
3. The changes in patient’s medications (i.e., the addition of anti-platelet therapies 
to reduce cardiovascular events) may have influenced these results.  
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4. The NIRS device assumes that the sample volume is 100% homogeneous. 
However, skeletal muscle biopsies were not obtained in the present study and 
thus it is not known if PAD patients had significant intramuscular fat or fibrosis 
that might have attenuated the NIRS signal.  
5. Intracellular myoglobin is similar in structure to hemoglobin and thus it is 
difficult to discern its contribution in the NIRS signal.  
6. The assumption that the muscle oxygen saturation can be altered with low-
intensity incremental supine plantar flexion exercise in PAD.  
7. The assumption that occlusive disease reduced blood flow to the medial 
gastrocnemius muscle to the same extent in all PAD patients. 
Hypotheses 
 
The study tested the following hypotheses: 
1. Revascularization will reduce the large drop in skeletal muscle oxygen saturation in 
PAD during graded plantar flexion exercise.  
2. The revascularization of blood flow will significantly reduce the exaggerated exercise 
pressor reflex observed in PAD.   
Definition of Terms 
 
Skeletal muscle oxygen saturation (SmO2). The ratio of oxygenated 
hemoglobin (O2Hb) concentration to total hemoglobin (tHb) concentration expressed 
as a percent (SmO2 = O2Hb/tHb) (Schmitz, 2015). As shown in Figure 2, SmO2 is 
quantified non-invasively via a technique called near-infrared spectroscopy (NIRS).  
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Fatigue. The time point where plantar flexion exercise was terminated at the 
pre-revascularization visit. Each subject’s post-revascularization data was then time 
matched to their previous visit fatigue time point. However, subjects may exercise 
beyond their fatigue point determined at the pre-revascularization visit. If this is the 
case, the time point will be referred to as “end exercise.”   
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Chapter 2 
Review of the Literature 
 
Epidemiology 
 
The most recent estimates suggest that 8 to 12 million people in the United States and 
200 million people worldwide are affected by PAD (Allison et al., 2007; Falk, 2006; Hiatt, 
Armstrong, Larson, & Brass, 2015; Hiatt et al., 2008; Hirsch et al., 2001; Patel et al., 2015; 
Selvin & Erlinger, 2004). The prevalence of PAD is reported to be greater in men (Hirsch et 
al., 2012; Hirsch et al., 2006; Norgren et al., 2007). However, in patients above the age of 85, 
there is a shift in prevalence as PAD becomes more common in women (Diehm et al., 2004; 
Hirsch et al., 2012). The estimated prevalence of PAD is determined by the systolic ankle-to-
brachial index (ABI) screening (see Diagnosing PAD, p. 11). Abnormal ABIs are detected in 
roughly 6% of people over 40 years old and 20% of people over the age of 65 (Pande, Perlstein, 
Beckman, & Creager, 2011). 
As PAD is a manifestation of systemic atherosclerosis, it is not surprising that patients 
with the disease have an increased risk of thromboembolic events (e.g., myocardial infarctions 
and  cerebral vascular accidents) as well as an increase in all-cause mortality (Ouriel, 2001); 
the likelihood of patients dying over the next 10 years is three times greater when compared to 
heathy individuals (Criqui et al., 1992). Furthermore, mortality as a consequence of coronary 
artery disease affects over half of the patients with PAD (Dormandy & Rutherford, 2000). 
Although, as treatments continue to improve, it is possible that other diseases like cancer will 
become the leading cause of death in this population.  
Risk factors for PAD include cigarette smoking, diabetes mellitus, increased age, 
hypertension, hypercholesterolemia, Hyperhomocysteinemia, chronic kidney disease, insulin 
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resistance, and increased C-reactive protein levels (Criqui & Aboyans, 2015; Guallar et al., 
2006; Muller, Reed, Leuenberger, & Sinoway, 2013; O'Hare, Glidden, Fox, & Hsu, 2004; 
Pande, Perlstein, Beckman, & Creager, 2008; Selvin & Erlinger, 2004).  Individuals who 
smoke significantly increase their risk of developing PAD, while risk decreases following the 
cessation of smoking (Criqui & Aboyans, 2015). Diabetes increases the risk of developing 
PAD (Marso & Hiatt, 2006). In PAD patients with diabetes and/or those that smoke show an 
increased risk of developing critical limb ischemia (a consequence of PAD that typically 
requires amputation of necrotic tissue or gangrene) (Beckman, Paneni, Cosentino, & Creager, 
2013). These same risk factors are also highly associated with coronary atherosclerosis and 
other forms of cardiovascular disease. Thus, aggressive management of risk factors is 
important when treating PAD. 
Pathophysiology 
 
PAD is atherosclerosis that affects the conduit arteries of the lower extremity (Hiatt, 
Hoag, & Hamman, 1995). Atherosclerosis is a chronic systemic inflammatory disease 
(Mullenix, Andersen, & Starnes, 2005) where arteries become progressively blocked by 
fibrofatty plaque deposits (Falk, 2006). This process is slow to develop and effectively reduces 
arterial blood supply to distal regions (i.e., skeletal muscles in the lower extremity). In most 
cases at rest, O2 supply satisfies O2 consumption. However, increases in metabolic demand 
(i.e., during walking exercise) result in O2 supply-demand mismatches. During these periods 
of limited O2 supply, exercising skeletal muscle becomes ischemic and some patients may 
develop walking leg pain, termed “intermittent claudication.” Exertional leg pain may occur 
in the buttocks, thigh, or calf region. This pain is alleviated by rest, allowing the return of blood 
flow to replenish the metabolic deficit. The etiology of the walking leg pain can be described 
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similarly to the way blockages of the coronary arteries result in angina. However, these 
hallmark symptoms (i.e., intermittent claudication) present in roughly 10% to 35% of patients, 
while 40% to 50% of patients present with atypical leg pain and the remaining 40% to 50% 
are asymptomatic (Hirsch et al., 2001; Hirsch et al., 2007; M. M. McDermott et al., 2001). Due 
to this nonspecific presentation, PAD has often been regarded as the most common form of 
cardiovascular disease that is most commonly underdiagnosed (Belch et al., 2003; Diehm et 
al., 2006; Hirsch et al., 2006; Rosero, Kane, Clagett, & Timaran, 2010).  
 Patients with PAD have increased vascular resistance. This increase is a result of a 
stenosis reducing blood flow. However, endothelial dysfunction and impaired vasodilation also 
contribute to the increase in total peripheral resistance.  Reductions in flow can be described 
by the Poiseuille equation: 
𝑄 =  
∆𝑃𝜋𝑟4
8𝜂𝑙
 
where (𝑄) is blood flow, (∆𝑃) is the change in pressure gradient across the stenosis, (𝑟) is the 
radius of the lumen, (𝜂) is the blood viscosity, and (𝑙) is the length (Badeer, 2001). Changes in 
vessel radius have a tremendous impact on flow. As the radius decreases, so too does flow. 
There is also a large pressure gradient that develops across stenotic lesions. With exercise, 
metabolic byproducts build up in the active tissue distal to the stenosis and promote local 
vasodilation. While blood flow is typically enhanced with vasodilation, the atherosclerotic 
plaque reducing the diameter of the arterial lumen ultimately dictates the amount of blood flow 
to distal regions. This vasodilation with a lack of blood flow could effectively lower perfusion 
pressure and worsen O2 kinetics. If the stenosis is small, there may be little disruption in flow, 
as the formation of collateral vessels help to promote blood flow past diseased areas (Coats & 
Wadsworth, 2005). However, in more severe cases, even collateral development cannot 
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overcome these obstructions. Often, the arterial system that feeds the collateral system can also 
become diseased causing further reductions in blood flow.  
Over time, PAD patients experience repetitive bouts of ischemia in the legs and develop 
skeletal muscle myopathy, microcirculatory, and mitochondrial dysfunction (Harwood, 
Cayton, Sarvanandan, Lane, & Chetter, 2016; Hiatt et al., 2015; Pipinos et al., 2007, 2008; 
Robbins et al., 2011). It has been shown that PAD patients suffer from a nearly tenfold greater 
decline of skeletal muscle mass (i.e., sarcopenia) when compared to healthy controls (Addison 
et al., 2018). Other pathological changes include reductions in capillary density, type 1 fibers, 
electron transport enzymes, the rate of phosphocreatine recovery after exercise, increases in 
lactate accumulation at low workloads, and abnormalities in the utilization of oxygen in active 
skeletal muscle (J. D. Anderson et al., 2009; Bauer, Brass, & Hiatt, 2004; Bauer, Brass, Nehler, 
Barstow, & Hiatt, 2004; Brass & Hiatt, 2000; Brass, Hiatt, Gardner, & Hoppel, 2001; Frisbee, 
Wu, Goodwill, Butcher, & Beard, 2011; Isbell et al., 2006; Pipinos, Shepard, 
Anagnostopoulos, Katsamouris, & Boska, 2000; Robbins et al., 2011). Together, these factors 
likely contribute to the walking impairment in PAD. 
Diagnosis 
 
There are several ways to diagnose PAD, however, the ambiguity in symptomology 
make this more difficult than other forms of cardiovascular disease. Questionnaires are used 
to gauge PAD symptoms and walking ability. The Rose questionnaire, The San Diego 
Claudication Questionnaire, and the Walking Impairment Questionnaire are all or partially 
PAD specific questionnaires commonly used to assess symptoms and level of impairment 
(Criqui & Aboyans, 2015; Criqui et al., 1996; Regensteiner, 1990; Rose, 1962). Patients may 
also present with physical findings such as skin atrophy and atypical hair loss on the legs 
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(Sontheimer, 2006). Apart from the history and physical examination, the ABI is typically the 
first test used to diagnose PAD. The test is easy to perform and cost effective. The ABI was 
first described by Winsor T. in 1950 and has since become the norm in noninvasively 
diagnosing PAD (Winsor, 1950; Yao, Hobbs, & Irvine, 1969). The ABI consists of bilateral 
BP measurements taken at the ankle (posterior tibial or dorsalis pedis artery) and brachial 
artery in the supine posture. The measurement is calculated by dividing the highest pressure in 
the ankle/foot by the highest pressure in the upper extremity. ABIs have been reported in the 
seated position, however, a correction factor must be applied (Gornik et al., 2008). According 
to the PAD guidelines from the American College of Cardiology and the American Heart 
Association, a normal ABI is 1.00 to 1.40 (Thom W. Rooke et al., 2011). ABI values above 
1.40 are indicative of calcified arteries. An ABI of 0.91 to 0.99 is considered borderline, while 
an ABI below 0.90 is considered abnormal (i.e., suggestive of atherosclerotic obstruction) 
(Thom W. Rooke et al., 2011). In general, lower ABI values indicate a more severe level of 
disease and a lower five-year survival rate (Resnick et al., 2004; T. W. Rooke et al., 2011). 
Patients with classic symptoms of intermittent claudication may present with an ABI in the 
range of 0.50 to 0.80. An ABI below 0.50 is often associated with critical limb ischemia caused 
by severe arterial insufficiency. Critical limb ischemia involves chronic ischemic rest pain, 
ulceration, and/or the development of gangrene (Norgren et al., 2007; Varu, Hogg, & Kibbe, 
2010), and if left untreated, critical limb ischemia typically results in the loss of limb. However, 
it is important to note that critical limb ischemia is considerably rare (occurring in only 1% to 
2% of the PAD population) (Hirsch et al., 2001; Hirsch et al., 2006). The ABI is a relatively 
quick objective assessment and has a specificity (83% – 99%) and sensitivity (69% – 73%) for 
the detection of stenotic lesions over 50% (Thom W. Rooke et al., 2011). The test can detect 
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PAD even in the absence of leg pain or classic symptoms. In fact, relying primarily on classic 
claudication symptoms could fail to detect most patients with PAD, while the ABI is more 
closely correlated to reductions in leg function (M. M. McDermott et al., 2002). It is important 
to note that PAD patients have a reduced ABI following walking exercise. Gardner and 
colleagues demonstrated that following graded treadmill exercise, the ABIs in PAD patients 
were lower for up to 10 minutes post exercise (Gardner, Skinner, Cantwell, & Smith, 1991). 
Thus, it is reasonable to use exercise testing to help confirm a diagnosis of PAD in patients 
where exercise testing is not contraindicated. Exercise tests, such as the six-minute walking 
test (6MW) and progressive treadmill tests (Gardner et al., 1991), are commonly used to 
identify claudication onset time (COT), peak walking time (PWT), and peak walking distance 
(PWD).  A patient with PAD will have reductions in these specific outcome measures and thus, 
will have impaired functional ability and increased morbidity and mortality (Criqui et al., 
1992). Exercise testing is also a useful tool to differentiate between disease progression and 
functional impacts.  
Other tests (segmental pressures, toe-brachial index, pulse volume recording, Doppler 
imaging, transcutaneous oxygen monitoring, and angiography) are used to identify the location 
and severity of the disease. A segmental pressure measurement uses a series of blood pressure 
cuffs placed at various levels on the leg. A reduction in pressure greater than 20 mmHg in the 
sequential segment is indicative of disease. Also, segmental pressure differences between legs 
greater than 30 mmHg is also considered indicative of PAD (Hirsch et al., 2006).  The toe-
brachial index (TBI) is similar to the ABI where a value less than 0.6 is indicative of PAD 
(Ramsey, Manke, & Sumner, 1983). Pulse volume recordings use the same pressure cuff setup 
as segmental pressures to obtain pulsatile volume changes in the legs. Decreases in pulse 
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volume amplitude and an absent dicrotic notch are considered abnormal (Darling, Raines, 
Brener, & Austen, 1972; Kempczinski, 1982). Doppler imaging uses ultrasonography to detect 
blood flow in arteries. Typically, the normal doppler waveform is triphasic with a prominent 
upward systolic peak followed by a slightly negative early diastolic wave and then a slightly 
positive late diastolic wave. In the presence of PAD, doppler waveforms are biphasic or 
monophasic (Sibley et al., 2017). An additional non-invasive measure is transcutaneous 
oxygen monitoring (TcPO2) which is useful for the assessment of severe ischemia (Cao et al., 
2011; Gerhard-Herman et al., 2017). Catheter-based imaging techniques, called angiography, 
are also used to identify the location and severity of the disease. These endovascular procedures 
are invasive and require the injection of contrast dye into the arterial system. Angiograms are 
typically performed to assist in the decision for treating patients with more aggressive 
endovascular or surgical procedures.  
Functional Disability 
 
It is important to note that patients with PAD (even those that are asymptomatic) 
experience functional decline (Mary McGrae McDermott, 2015; M. M. McDermott et al., 
2010; M. M. McDermott, Fried, Simonsick, Ling, & Guralnik, 2000; M. M. McDermott et al., 
2002). Many patients may develop exercise intolerance (Askew et al., 2005; M. M. McDermott 
et al., 2002) that can impact activities of daily living and significantly exacerbate the 
progression of the disease (Regensteiner, Wolfel, et al., 1993). Patients with PAD develop 
functional decline secondary to atherosclerotic vascular obstruction(s). Functional disability 
includes walking impairment (i.e., inability to walk six minutes without stopping, reduced 
treadmill walking time, and an inability to climb stairs). The 6-minute walk distances have 
been extensively reported over the years in both healthy populations as well as in PAD 
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(Addison et al., 2018; Camarri, Eastwood, Cecins, Thompson, & Jenkins, 2006; Casanova et 
al., 2011; M. M. McDermott et al., 2011). These functional declines are greater and more rapid 
in PAD compared to healthy persons without atherosclerotic disease (M. M. McDermott et al., 
2010; M. M. McDermott et al., 2000; M. M. McDermott et al., 2002; M. M. McDermott et al., 
2001; M. M. McDermott et al., 2009; M. M. McDermott et al., 2004). Women with PAD have 
been shown to experience faster functional decline than men, thought to be caused by reduced 
muscle mass at baseline (M. M. McDermott et al., 2011). In addition to reductions in physical 
activity correlating with increased mortality and cardiac events (Garg et al., 2006), PAD 
patients have a reduced quality of life and an increased incidence of depression (Regensteiner 
et al., 2008; Smolderen et al., 2009). 
In general, patients with lower ABIs have greater functional impairment and have to 
stop more frequently during walking exercise (M. M. McDermott et al., 2002). However, most 
patients with PAD do not experience the classical symptoms (i.e., intermittent claudication) 
(Hirsch et al., 2007; Mary McGrae McDermott, 2015; M. M. McDermott et al., 2001). In fact, 
in the Rotterdam Study, of the subjects with abnormal ABIs (i.e., < 0.90), only 6.3% 
experienced intermittent claudication (Meijer et al., 1998). It is unclear whether physical 
inactivity contributes to atypical symptomology. In other words, some PAD patients who are 
not active enough to elicit symptoms, may not seek out their healthcare provider.  
Recent studies suggest that slow gait speed (i.e., ≤ 0.8 m/s) and gait mechanics are 
associated with poor health outcomes in PAD (Gardner, Forrester, & Smith, 2001). The 
Gardner treadmill protocol is commonly used to assess the severity of functional walking 
impairment in PAD (Gardner et al., 1991). The protocol consists of treadmill walking at a 
constant speed of 2 miles per hour (0.89 m/s). Starting at a grade of 0%, the grade is increased 
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by 2% every 2 minutes until fatigue. Patients rate their level discomfort every minute via a 
zero to four scale (0 = no discomfort, 1 = onset of discomfort, 2 = moderate discomfort, 3 = 
severe discomfort, 4 = maximal discomfort). Claudication onset time (COT) is defined as the 
walking time before the onset of leg discomfort (i.e., 1 on the discomfort scale). Patients are 
instructed to walk until maximal discomfort (i.e., 4 on the discomfort scale). Peak walking 
time (PWT) is defined as the total walking time of the protocol. While treadmill testing 
confirms the degree of functional decline in PAD, it requires longer time, equipment, and 
personnel to conduct accurate screening protocols.  
Treatment 
 
While developments have been made in stent design, when compared to other forms of 
cardiovascular disease, there are limited treatment options for PAD patients. Treatment options 
include management of risk factors, pharmacological management to lower the risk of cardiac 
events and reduce symptoms, endovascular and surgical revascularization procedures to restore 
or improved blood flow to the leg(s), and exercise therapy. 
Initial treatment begins with modifications of risk factors, including smoking, diabetes 
mellitus, hypertension, and dyslipidemia. As smoking is the largest contributing risk factor, all 
patients are strongly encouraged to quit when diagnosed with PAD. Medications are prescribed 
to help control other risk factors. Patients will typically be prescribed an anti-platelet 
medication (i.e., acetylsalicylic acid or clopidogrel), statins, and possibly cilostazol. Cilostazol 
is one of two phosphodiesterase type three inhibitors that are approved by the Food and Drug 
Administration (FDA) for the treatment of claudication in PAD. The other FDA approved drug, 
Pentoxifylline, is typically not prescribed as it has been shown that it is no more effective than 
placebo in improving maximum walking distance (Dawson et al., 2000).  
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Revascularization procedures can be done endovascularly or surgically to reestablish 
blood flow (see figure 1). Endovascular revascularization is a catheter-based approach that 
consists of angioplasty, stenting, or atherectomy. These procedures are considered minimally 
invasive. Balloon angioplasty was first described by Dotter and Judkins (Dotter & Judkins, 
1964) and involves placing a deflated balloon into the artery via a percutaneous transluminal 
catheter. The deflated balloon is advanced over a guidewire to the level of the stenosis and 
dilated. The dilated balloon forces open hardened plaque in the vessel wall and increases the 
vessel lumen diameter thus improving blood flow to the distal vasculature. Patency with 
angioplasty is greatest in the aortoiliac region and gradually decreases in the distal vasculature 
(Norgren et al., 2007). However, balloon angioplasty is less effective at treating long and more 
complex lesions when compared to stents (Mewissen, 2009). A stent is a metal structure that 
can be placed on a balloon catheter and expanded in areas of stenosis. The placement of a stent 
can help to open the vessel lumen and improve patency (Vogel, Shindelman, Nackman, & 
Graham, 2003). However, stents placed in the lower extremity can be subjected to high 
mechanical stress from movement (e.g., bending of the hip and knee joints). Stent placement 
is also avoided in the common femoral artery as it can interfere with arterial access during 
future interventions (Kullo & Rooke, 2016). Thus, lesions in the common femoral artery are 
often treated surgically using endarterectomy (Farber, 2018). Atherectomy is a endovascular 
procedure that cuts or shaves atherosclerotic plaques and removes them from vessel walls 
effectively increasing lumen size (Bhat, Afari, & Garcia, 2017) although it is unclear whether 
this technique outperforms balloon angioplasty or stents (Ambler, Radwan, Hayes, & Twine, 
2014). Surgical revascularization procedures (e.g., bypass or endarterectomy) are typically 
reserved for patients where endovascular revascularization is not possible or previous 
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interventions have failed (Kullo & Rooke, 2016).  These procedures are invasive and are 
generally associated with greater risk, however, surgical bypass is associated with high patency 
(Chiu, Davies, Nightingale, Bradbury, & Adam, 2010). Bypass can be accomplished by using 
prostatic grafts or a vein graft, typically made with the great saphenous vein. Bypass is an 
aggressive treatment option for patients with symptomatic PAD; however, it is generally the 
standard for patients suffering from critical limb ischemia (Gardner & Afaq, 2008). The goal 
of both surgical and endovascular revascularization is to improve blood flow and reduce the 
incidence of tissue loss that may require amputation. While symptoms are often improved with 
these procedures, they do not entirely improve function in all patients (Oresanya et al., 2015). 
A large collection of evidence supports the use of exercise therapy, either alone or in addition 
to the treatment options previously described, for optimal improvements in functionality 
(Treat-Jacobson et al., 2019).       
The addition of supervised exercise training (SET) is arguably the largest change in the 
management of PAD in recent years (Jensen, Chin, Ashby, Schafer, & Dolan, 2017; M. M. 
McDermott, 2018; Treat-Jacobson et al., 2019). Medical insurance coverage includes 12-
week/36 sessions that recommend walking based exercise be done at least three times per 
week, for at least a total of 30 minutes a day. SET is to be done in a healthcare setting and 
under the supervision of a physician. Currently, the American College of Sports Medicine 
(ACSM) recommends supervised exercise training consists of aerobic exercise (e.g., free or 
treadmill walking) to the point of moderate pain on the claudication pain scale (Treat-Jacobson, 
Henly, Bronas, Leon, & Henly, 2011) for three to five days per week. The duration of exercise 
bouts may vary based on disease severity; however, a total of 30-45 minutes per week 
(excluding periods of rest) and may progress to 60 minutes a day or more (American College 
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of Sports, Riebe, Ehrman, Liguori, & Magal, 2018). Resistance exercise may be recommended 
for patients with PAD (American College of Sports et al., 2018) as patients develop muscle 
myopathy and suffer from reductions in lower extremity muscle mass. However, resistance 
exercise training is not as beneficial as aerobic exercise training for improving 6-minute walk 
distance in PAD (Mary M. McDermott et al., 2009).   
The evidence for benefits of SET in PAD is vast and dates back to the 1960’s (Larsen 
& Lassen, 1966). Recent studies by Gardner and colleagues suggest that both SET and 
homebased exercise training is beneficial in PAD (Gardner, Parker, Montgomery, & Blevins, 
2014; Gardner, Parker, Montgomery, Scott, & Blevins, 2011). In an early study by Lundgren 
and colleagues, a randomized comparison between SET, revascularization, and SET plus 
revascularization in 75 PAD patients showed that walking function improved across all three 
groups. However, walking performance was significantly greater in patients that underwent 
revascularization plus SET (Lundgren, Dahllof, Lundholm, Schersten, & Volkmann, 1989). 
Since Lundgren’s initial study, several other studies indicated that revascularization plus SET 
showed favorable results for improving walking function (Creasy, McMillan, Fletcher, Collin, 
& Morris, 1990; Mazari et al., 2010; Mazari et al., 2012). In one large trial involving 212 PAD 
patients, those that underwent SET plus endovascular revascularization had a longer peak 
walking distance when compared to individuals that received only SET (Fakhry et al., 2015). 
However, one study by Gelin et al has shown that walking ability improved in the 
revascularized group compared to SET. The CLEVER study showed that SET and stenting 
improved peak walking time over optimal medical care in 111 PAD patients (T. P. Murphy et 
al., 2012; Timothy P Murphy et al., 2015). These data suggest that both revascularization and 
SET improves walking performance. Moreover, SET may be just as effective as endovascular 
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interventions for improving walking performance, and when done in conjunction, their effects 
appear to complement one another.  
The Exercise Pressor Reflex 
 
While exercise therapy and increased activity is clearly beneficial for PAD patients, it 
is important to note that these individuals have an abnormal cardiovascular response to 
exercise. A reductions in blood flow to exercising skeletal muscle has been shown to activate 
a sympathoexcitatory pathway, termed the exercise pressor reflex (EPR) (Alam & Smirk, 
1937; Augustyniak, Ansorge, & O'Leary, 2000; Kaur et al., 2015). This phenomenon was first 
observed in the 1930’s when Alam and Smirk used various techniques to occlude the 
circulation in exercising legs and forearms. The study showed reflex increases in BP and HR 
post exercise while the limb was left occluded. The study was the first to suggest that there 
was a neural component to the reflex because circulating metabolites were confined to the 
occluded limb. The neural control of the circulation has since been extensively expanded on 
by others (Coote, Hilton, & Perez‐Gonzalez, 1971; Goodwin, McCloskey, & Mitchell, 1971; 
McCloskey & Mitchell, 1972). In animal studies, it was discovered that when stimulated by 
muscle contraction, thin fiber muscle afferents (i.e., groups III and IV) evoked the exercise 
pressor reflex (Kaufman et al., 1983). From here, Kaufman and others have described the 
functional properties of group III (mechanoreceptors) and group IV (metaboreceptors) muscle 
afferents and their involvement in the EPR (Ellaway, Murphy, & Tripathi, 1982; Kaufman et 
al., 1983; Kaufman et al., 1984; Kenagy, VanCleave, Pazdernik, & Orr, 1997; Kumazawa & 
Mizumura, 1977; Mense & Stahnke, 1983; Paintal, 1960; Sinoway, Hill, Pickar, & Kaufman, 
1993). It has been concluded that the exercise pressor reflex serves as a feedback mechanism, 
arising from the contracting skeletal muscle, that increases the cardiovascular response to meet 
 23 
the metabolic demands of exercise (Stone & Kaufman, 2015). Animal models of PAD using 
femoral artery ligation have been used to show the activation of the EPR in reductions of blood 
flow to skeletal muscle (Waters, Terjung, Peters, & Annex, 2004). However, large artery 
hemodynamics do not fully explain symptomology in PAD patients (Brass, Hiatt, & Green, 
2004; Gardner, Skinner, Cantwell, & Smith, 1992). Nevertheless, the rise in arterial BP is 
related to an increased risk of adverse cardiovascular events in patients with PAD (de et al., 
2008; Lewis et al., 2008; Weiss, Blumenthal, Sharrett, Redberg, & Mora, 2010).  
Skeletal Muscle Oxygen Saturation in Peripheral Artery Disease 
 
During aerobic exercise, oxygen supply must equal the amount of oxygen consumed 
by the active skeletal muscle. This relationship between the uptake of oxygen (V̇O2) and 
oxygen delivery via cardiac output (Q̇) is one of the fundamental principles of exercise 
physiology as first described by Adolph Fick (Fick, 1870). The Fick equation is defined as: 
?̇?𝑂2 =  ?̇? × (𝑎 − 𝑣?̇?2𝑑𝑖𝑓𝑓𝑒𝑟𝑒𝑛𝑐𝑒) 
where a – v O2 difference is the change in oxygen concentration across the microcirculation. 
During aerobic exercise, the a – v O2 difference widens (i.e., the venous oxygen concentration 
falls, and the arterial oxygen concentration is normally maintained) and subsequently widens 
the partial pressure of oxygen gradient in the skeletal muscle and improves oxygen diffusion. 
As V̇O2 increases, so too does Q̇ and a – v O2 difference. Whole body oxygen uptake can be 
measured using pulmonary metabolic gas analyzer. However, this technique does not allow for 
the quantification of localized skeletal muscle oxygen consumption. Other techniques that 
include magnetic resonance imaging or arterial/venous catheterization are expensive, invasive, 
or are generally not conducive for exercise studies.  
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Recently, NIRS has been used to assess microvascular oxygen kinetics across several 
muscles (Chris J McManus, Jay Collison, & Chris E Cooper, 2018). This technique was first 
described by Jöbsis in 1977 (Jobsis, 1977). The NIRS device provides noninvasive measures 
of oxygenated hemoglobin (O2Hb), deoxygenated hemoglobin (HHb), and microcirculatory 
O2 saturation where SmO2 is the ratio of O2Hb to total hemoglobin (tHb; tHb = O2Hb + HHb) 
expressed as a percentage [SmO2 = O2Hb/(tHb)]. The use of NIRS in muscle O2 kinetics has 
been extensively reviewed (Ferrari, Muthalib, & Quaresima, 2011; Grassi & Quaresima, 2016; 
Hamaoka, McCully, Niwayama, & Chance, 2011; Jones, Chiesa, Chaturvedi, & Hughes, 
2016). Once the device is placed on the patient, NIRS light travels through the underlying 
tissue in an arcing pathway from the emitter to the detector (Figure 2). Attenuation of light is 
caused by the scattering of light equally in all directions as it is emitted from the light source.  
Light is then absorbed by O2Hb and HHb, and to some extent myoglobin, intracellular and 
extracellular water, and pigment in skin. Knowing the absorptive properties and using multiple 
source detectors at different distances can improve and isolate muscle tissue for quantification 
of SmO2. Absorbance (A) in a tissue is defined as: 
𝐴 =  log 10 (
𝐼1
𝐼0
) 
Where I1 is the transmitted light and I0 is the source light. As more light is adsorbed by 
the tissue, less light is transmitted back to the detector. The absorbance of light can be 
explained by Beer Lambert Law: 
𝐴 =  log 10 (
𝐼1
𝐼0
) =  𝜀𝑏𝑐 
Where ε is the known molecular extinction coefficient, b is the known path length, and 
c is the known concentration. Commercially available NIRS devices work from this principal 
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in that the source-detector distance is known and the extinction coefficients for O2Hb and HHb 
are known. Transmitted light can be measured, and the concentrations of O2Hb and HHb can 
be quantified. The device used in the present investigation utilizes a four-layer (epidermis, 
dermis, adipose, and muscle) Monte Carlo model. The monitor also uses one light source, a 
short and long-distance detector, and an algorithm in an attempt to isolate the skeletal muscle 
signal from the superficial skin and adipose layer. NIRS is able to track changes in skeletal 
muscle oxygenation during exercise (C. J. McManus, J. Collison, & C. E. Cooper, 2018) and 
is often used in research in patients with PAD (Bauer et al., 2007; Bauer, Brass, & Hiatt, 2004; 
Gardner et al., 2014; Halber, Posner, & McCully, 1994; Murrow et al., 2019). It is not known 
if these measures are influenced by severity of disease. For the present study, NIRS is a 
valuable measure to investigate the exercise response in patients treated for symptomatic PAD. 
During exercise, local and systemic cardiovascular adjustments promote hyperemia in 
active tissue to increase the delivery of oxygen to active tissue. However, as previously stated, 
patients with PAD experience chronic reductions in skeletal muscle blood flow (and thus, 
reduced oxygenation) during dynamic exercise, as well as an exaggerated exercise pressor 
reflex (Baccelli et al., 1999; Bakke et al., 2007; Luck et al., 2017; Miller et al., 2018; Miller et 
al., 2017; Muller et al., 2012; Muller et al., 2015). The use of NIRS is a practical tool to help 
investigate improvements in perfusion following revascularization and whether or not it 
contributes to other improvements in cardiovascular function, as previously shown (Miller et 
al., 2018). 
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Chapter 3 
Methods 
 
Participants  
Male and female patients with PAD (n=6) completed the present study. Subjects were 
preliminarily screened from the Penn State Heath vascular clinic lists or previous enrolled 
studies and contacted by the study coordinator/clinical research nurses. All experiments were 
approved in advance by the Institutional Review Boards of the Penn State Milton S. Hershey 
Medical Center and Appalachian State University and conformed with the Declaration of 
Helsinki. All subjects provided written and informed consent. All contacted patients had 
received a previous diagnosis of PAD (i.e., ABI < 0.9) and were scheduled for a standard-of-
care vascular procedure at Penn State. PAD patients with diabetes were included if stable on 
their medications and showed no significant symptomatic peripheral neuropathy. PAD patients 
with a recent history of unstable angina or myocardial infarction (<6 months), current unstable 
angina or a primary symptom of angina, and/or elevated serum creatinine >2.0 mg/dl that 
would be indicative of renal failure were excluded. Patients were also excluded if they had 
signs and symptoms of severe PAD (e.g., resting leg pain or open non-healing wounds). 
Individual subject characteristics (age, location of arterial occlusion, height, weight, and pre- 
and post-revascularization ABI) are shown in Table 1. Four of the six subjects had 
hyperlipidemia, three had coronary artery disease, three were hypertensive, one had chronic 
obstructive pulmonary disease, and one had peptic ulcer disease (Table 2).  
Patients underwent lower extremity revascularization procedures (Table 3). Of the six 
patients in the study, four received balloon angioplasty and four received stents (two received 
both). Two of the six patients underwent endarterectomy. Stents were placed in the common 
iliac artery (3/6) and in the external iliac artery (1/6). Bilateral kissing stents were placed in 
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the iliac arteries in one patient. Patients maintained their usual medication regimen during the 
study (Table 4), including clopidogrel (6/6), statins (5/6), acetylsalicylic acid (4/6), beta 
adrenergic receptor blockers (4/6), angiotensin-converting-enzyme inhibitors (3/6), proton 
pump inhibitors (2/6), bronchodilators (2/6), diuretics (2/6), multivitamins (2/6), 
antidepressants (1/6), calcium channel blockers (1/6),  anti-diabetic medications (1/6),  
anticonvulsants (1/6), coenzyme Q10 (1/6),  and vitamin D (1/6). Subjects were taking the same 
medications and doses for both visits; however, three patients began antiplatelet therapy after 
their intervention, per the standard of care following revascularization procedures. All 
participants reported a previous history of smoking, and one of the six patients was currently 
smoking.  
Experimental Design and Measures 
The present study utilized a pre-experimental, pretest-posttest design where each 
subject served as their own control. Subjects reported to the laboratory after refraining from (i) 
caffeine for at least 12 hours and (ii) all over-the-counter medications, alcohol, and extreme 
exercise for 24 hours before the visit. The laboratory room temperature was maintained 
between 22 and 25 °C during all visits. After resting for several minutes, supine ABIs were 
measured on both the right and left side. Two continuous-wave NIRS monitors (MOXY 
muscle oxygen monitor; Fortiori Design, Hutchinson, MN) were attached to the right and left 
calf at the region of the medial gastrocnemius. Wavelengths at approximately 750 and 850 nm 
were used (Matcher, Cope, & Delpy, 1997). To ensure proper signal penetration depth, adipose 
tissue thicknesses (ATT) was obtained using ultrasound imaging (iE33, Philips) at each NIRS 
probe site. In 2D mode, an average of three manually selected distances was measured from 
the epidermis to the superficial aponeurosis using a L11-3 linear array transducer. A NIRS 
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source-detector separation of 30 mm was used allowing for a sufficient signal penetration depth 
(~15 mm), approximately one-half of the source-detector separation distance. Next, a custom-
made wooden sandal was attached using Velcro straps to the foot of the leg that the subject 
was scheduled to receive an intervention (Figure 3). The wooden sandal device was attached 
to a load cell pulley system at the head of the patient bed by which individual weights could 
be added to a bucket by the investigators. The custom-made wooden device has been used in 
several previous studies in our laboratory (Drew et al., 2013; Luck et al., 2017; Muller et al., 
2012; Muller et al., 2015). A cushion was placed under the thigh and ankle, slightly elevating 
the leg to reduce the influence of venous congestion in the limb. Three sticky ECG electrodes 
were placed on the patient’s chest/abdomen in which heart rate (HR) and cardiac rhythm were 
monitored using a three-lead electrocardiogram (ECG) (Cardiocap/5; GE Healthcare, 
Waukesha, WI). A brachial artery blood pressure cuff (Philips SureSigns VS3, Andover, MA) 
was placed on the subject’s right arm and measurements were taken in triplicate prior to 
starting the baseline. A finger blood pressure cuff was placed around the left middle phalanx 
of the III or IV digit in which beat-to-beat blood pressure was measured continuously using 
finger plethysmography (Finometer, FMS, Arnhem, The Netherlands). Subjects were briefly 
coached on the proper exercise cadence along with the metronome sound cue.    
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Figure 3. Experimental setup. A custom-made wooden sandal with weight and pully system 
attached to a patient’s foot is shown.  
Experimental Visit 1  
Following a three-minute baseline, patients underwent supine plantar flexion exercise 
with the most symptomatic leg starting at 0.5 kg and increasing by 0.5 kg in load every minute 
until fatigue. Two NIRS monitors were attached to the right and left calf at the region of the 
medial gastrocnemius. BP and HR were monitored on a beat-by-beat basis during the study. 
ATT was assessed using ultrasound to ensure the NIRS signal reached the correct tissue depth 
to penetrate the skeletal muscle.   
 
 
Figure 4. Exercise protocol. Following a baseline period, subjects performed supine plantar 
flexion at 30 contractions per minute with no pause in between contractions for a total of six 
minutes. A metronome was used to insure proper cadence. Weight was added to a weight 
bucket at the head of the bed in 0.5 kg/minute increments.   
Experimental Visit 2 
One month following endovascular or surgical intervention in the lower extremity, 
patients returned for a second laboratory visit. ABI measurements were repeated and the NIRS 
monitors were attached in a similar fashion as experimental visit 1 over the right and left medial 
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gastrocnemius. The measures and exercise protocols were identical to those conducted in visit 
1. 
Data Collection and Statistical Analysis 
Data were collected continuously at 200 Hz and analyzed offline (PowerLab, 
ADInstruments, Castle Hill, NSW, Australia). NIRS values were collected wirelessly via 
ANT+ at 2 Hz and transmitted to an offline laptop with ANT+ antenna for offline analysis 
(PeriPedal v2.4.8; Napoleon, IN). Statistical analyses were performed using IBM SPSS 23.0 
software, and graphics were produced using Microsoft Excel. All exercise data were 
averaged into 20-second bins and the last 20-seconds of each workload were used for 
statistical analysis. Individual and mean data are presented in changes (Δ) from baseline to 
1.5 kg (3 minutes completed) and from baseline to end exercise (i.e., the point at which the 
subject completed the 3.0 kg, six-minute protocol or stopped prior to completing the protocol 
due to claudication symptoms). All data were compared with a paired-samples t-test because 
not every subject completed every stage of the protocol. Data are presented as means (M) ± 
standard deviation (SD) and P values of <0.05 were considered statistically significant.  
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Chapter 4 
Results  
As shown in Table 1, six patients with mild to moderate PAD (2 females and 4 males 
ranging in ages 55 to 78 years) completed pre- and post-revascularization laboratory visits. 
Four of the six patients had an improved ABI post-revascularization, while patient 1 improved 
by only 0.01 and patient 6 decreased from 0.83 to 0.76.   
 
 
 
 
 
  
Table 1. Subject characteristics. 
Patient Location of Arterial Occlusion  
Age 
(yr) 
Height 
(cm) 
Weight 
(kg) 
ABI 
PRE 
ABI POST 
1 (F)    Aortoiliac 55 165.1   68.7 0.77 0.78 
2 (M)    Femoral-Popliteal 69 182.9 102.5 0.48 0.83 
3 (M)    Femoral-Popliteal 67 175.3 118.2 0.79 0.97 
4 (F)    Aortoiliac 66 162.6   78.5 0.52 1.01 
5 (M)    Aortoiliac and Femoral 78 175.3   85.6 NC 0.52 
6 (M)    Bilateral Femoral 63 170.2   83.2 0.83 0.76 
             
M   66 171.9 89.4 0.68 0.81 
SD     3     3.1   7.3 0.14 0.07 
Individual age, height, weight, and supine ankle-brachial index (ABI) pre- (PRE) and one-
month post-intervention (POST) in PAD patients (n=6). Data are expressed as means (M) and 
standard deviation (SD). NC, non-compressible.  
Table 2. Subject comorbidities. 
Comorbidity Number of patients 
Hyperlipidemia (4/6) 
Coronary artery disease (3/6) 
Hypertension (3/6) 
Chronic obstructive pulmonary disease (1/6) 
Peptic ulcer disease (1/6) 
The number of patients with previously diagnosed comorbidities.   
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As shown in Figure 5, changes in muscle oxygenation (SmO2), assessed with NIRS, 
are presented for each patient pre- and one-month post revascularization. All six subjects 
Table 3. The location and number of endovascular or surgical revascularization procedures. 
Type and location Number of patients 
Balloon angioplasty (4/6) 
     CIA (2/6) 
     SFA (2/6) 
Stent (4/6) 
     CIA (3/6) 
     EIA (1/6) 
Endarterectomy (2/6) 
     CFA (2/6) 
     EIA (1/6) 
     DFA (1/6) 
After visit 1, all subjects underwent endovascular or surgical revascularization. CIA, common 
iliac artery; EIA, external iliac artery; CFA, common femoral artery; SFA, superficial femoral 
artery; DFA deep femoral artery  
Table 4. Pharmacological treatment. 
Medications Number of patients 
Clopidogrel  
     PRE (3/6) 
     POST (6/6) 
Acetylsalicylic acid (4/6) 
Beta adrenergic receptor blockers (4/6) 
Angiotensin-converting-enzyme inhibitors (3/6) 
Proton pump inhibitors (2/6) 
Bronchodilators (2/6) 
Diuretics (2/6) 
Multivitamins (2/6) 
Antidepressants  (1/6) 
Calcium channel blockers  (1/6) 
Anti-diabetic medications (1/6) 
Anticonvulsants (1/6) 
Coenzyme Q10  (1/6) 
Vitamin D  (1/6) 
After visit 1, all subjects underwent endovascular or surgical revascularization. CIA, common 
iliac artery; EIA, external iliac artery; CFA, common femoral artery; SFA, superficial femoral 
artery; DFA deep femoral artery  
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completed at least the 1.5 kg stage at the pre-revascularization visit while two patients 
completed the entire 3.0 kg protocol. During the post-revascularization visit, all six subjects 
completed the 2.5 kg workload with three completing the entire 3.0 kg protocol. 
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Figure 5. Individual muscle oxygenation responses to plantar flexion exercise in PAD patients 
(n=6) pre- and one-month post-revascularization. Data are collected from the medial 
gastrocnemius muscle and represent a change (Δ) from rest to end exercise. 
 
The ΔSmO2 improved post-revascularization at 1.5 kg workload (-36 ± 9 %, PRE vs. -
1 ± 2 % POST, P < .05). Similarly, the Δ heart rate was decreased post- revascularization (6 ± 
1 bpm, PRE vs. 3 ± 1 bpm, POST, P < .05). Exercise intensity that was matched at 1.5 kg did 
not produce significant findings for blood pressure measurements. When changes were 
compared from rest to end exercise, as shown in Figure 7, the ΔSmO2 improved post-
revascularization (-40 ± 9 % PRE vs. -7 ± 3 % POST, P < .05).  The end exercise systolic 
blood pressure was reduced following revascularization (16 ± 6 mmHg PRE vs. 11 ± 4 mmHg 
POST, P < .05) as was mean arterial blood pressure (16 ± 4 mmHg PRE vs. 7 ± 3 mmHg 
POST, P < .05). 
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Figure 6. Systemic hemodynamic and muscle oxygenation responses to plantar flexion 
exercise pre- and one-month post-revascularization. Values represent changes (Δ) from rest to 
end exercise. Large solid circles and large dashed lines indicate mean values and * indicates 
significant (p < 0.05) difference between pre- and one-month post-revascularization. SmO2, 
skeletal muscle oxygen saturation; HR, heart rate; SBP, systolic blood pressure; DBP, diastolic 
blood pressure; MAP, mean arterial blood pressure. 
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Chapter 5 
Discussion 
 
The purpose of this study was to examine whether responses in skeletal muscle oxygen 
saturation to foot exercise improved one-month post revascularization for the treatment of 
symptomatic PAD. The novel finding in this study was that oxygenation improved at both 1.5 
kg workloads and at fatigue. The blood pressure in PAD patients was improved at end exercise. 
These results are consistent with previous findings that blood pressure is improved one-month 
post-revascularization. (Miller et al., 2018). Although the study did not explicitly test for 
changes in sympathetic nerve traffic, the improvement in muscle oxygenation post-
revascularization could have played a role in attenuating the exercise pressor reflex.  
Effect of Revascularization on Skeletal Muscle Oxygen Saturation 
 
 During exercise, PAD patients have a rapid drop in muscle oxygenation (Bauer et al., 
2007; Bauer, Brass, & Hiatt, 2004; Gardner et al., 2019; Luck et al., 2017; McCully et al., 
1994; Miller et al., 2017). There does not appear to be a difference in resting oxygenation in 
PAD. However, initial reductions in oxygenation during exercise are thought to be caused by 
a widening of the a-v O2 difference as a result of arterial occlusion. A previous study by 
Comerota et al hinted that assessing oxygenation before and after revascularization may be 
important (Comerota, Throm, Kelly, & Jaff, 2003). However, to the best of the author’s 
knowledge, the present study is the first to do so. To date, revascularization appears to be the 
only thing that rapidly improves oxygenation for up to one month in PAD patients. In one 
previous study, dietary nitrate supplementation has been shown to improve exercise 
oxygenation values assessed with NIRS 180 min post-beverage consumption (Kenjale et al., 
2011). It is likely that occlusive disease and endothelial dysfunction contributes to these results. 
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Following revascularization, perfusion to the limb is improved (indicated by an increase in 
ABI) and may cause the large improvement in saturation during exercise.   
Effect of Revascularization on the Exercise Pressor Reflex 
 
 Plantar flexion exercise has been shown to elicit a blood pressure raising response 
called the exercise pressor reflex in patients with PAD (Lorentsen, 1972; Luck et al., 2017; 
Miller et al., 2018; Muller et al., 2012; Ross et al., 2017). This rise in blood pressure may be 
caused by sensitization of skeletal muscle nerve fibers that can detect a buildup of metabolic 
compounds in active tissue. An afferent signal travels to the cardiovascular control centers in 
the medulla and results in increased sympathetic outflow to the heart and blood vessels of non-
active skeletal muscle tissues. Several studies have shown that the exercise pressor reflex is 
present with a reduction in calf muscle oxygen saturation during exercise (Gardner et al., 2019; 
Luck et al., 2017; Miller et al., 2017). The present study suggests that by improving large artery 
blood flow, the exercise pressor reflex is improved at end exercise. While this response was 
small, it is possible that the post-revascularization blood pressure response could be more 
pronounced with more vigorous exercise (e.g., during free or treadmill walking).   
Limitations 
 
As with many studies in clinical populations, it is difficult to control for covariates 
(e.g., medications or other treatments) as it would be considered unsafe and/or unethical to 
interfere with patient care. The PAD patients had different disease locations and received 
different revascularization treatments for these locations. Although all patients remained on 
their usual medication regimen, three patients were started on clopidogrel, an anti-platelet 
medication, following revascularization. It is unclear whether clopidogrel influenced the NIRS 
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signal in these individuals. However, the other three subjects, who were taking the medication 
at both visits, showed modest improvements in muscle oxygenation. Apart from these 
limitations, the results of the study leave several unanswered questions. First, the reduction in 
muscle oxygen saturation is indicative of either poor tissue perfusion or increased oxygen 
extraction. However, large artery hemodynamics were not assessed and therefore, it is unclear 
if the increase in blood pressure during these low intensities was flow restorative. Future 
studies should investigate femoral blood flow using Doppler ultrasound to understand the 
changes in responses in large artery hemodynamics to exercise pre- and post-revascularization. 
To address the issue of extraction versus perfusion at low intensity exercise, utilizing T2*-
weighted magnetic resonance imaging could better address this issue. Lastly, it is unclear 
whether these same results translate to more vigorous exercise tests (e.g., the six-minute walk 
test or progressive treadmill test (Gardner et al., 1991)). However, as walking function tends 
to improve in PAD patients post-revascularization (and maybe more so when SET is added to 
patient treatment (Treat-Jacobson et al., 2019)), any improvements in cardiovascular 
parameters during exercise could have great clinical significance.   
Conclusions 
 
In conclusion, these data suggest the revascularization procedures for the treatment of 
PAD improve muscle oxygenation and lower blood pressure during dynamic foot exercise. 
These findings contribute to scientific field in that revascularization treatments, that are 
intended to improve large artery blood flow, may also have positive benefits on cardiovascular 
adjustments to dynamic exercise.   
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